戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              Syngenic and allogeneic corneal tissues deprived of epit
2 rtening did not differ between nonrejecting, syngenic and rejecting, allogenic transplants.
3 and infect tumor and metastases is proven in syngenic and transplanted tumors in different animal mod
4                           Using a variety of syngenic and xenograft models, we demonstrate here that
5                       When transplanted in a syngenic animal pretreated with RS, rAECs were able to e
6 lateral limb ischemia, bone marrow MNCs from syngenic B(2)R-deficient mice resulted in reduced homing
7 o day 7 s.c. CMS4 sarcoma lesions growing in syngenic BALB/c mice, DC.mTbets dramatically slowed tumo
8 verexpressing Renca cells were injected into syngenic BALB/c mice, there was a consistent and signifi
9 n ventricular myocytes freshly isolated from syngenic (Balb/C into Balb/C) and allogenic (Balb/C into
10       In this study, we show that, following syngenic BMT, the in vivo administration of rIL-7/HGFbet
11 ificant inhibitory effect on tumor growth in syngenic breast 4T1 and colorectal HT-29 cancer xenotran
12 on of human ES-2 ovarian cancer cells, and a syngenic C57BL/6 model, established by i.p. inoculation
13 rmal CD40L exons 2-5 and was administered to syngenic CD40L-knockout mice.
14 ansplantation is depressed to 40% of that of syngenic controls, and that this depression of function
15 ain (DA) to Wistar furth rat strain rats and syngenic DA-DA grafts were used as controls.
16                                              Syngenic DBA/2 tumor-bearing mice treated with HSV-1 171
17 A suppresses S91 melanoma growth in vivo, in syngenic DBA2 mice.
18 s followed by grafts to the lesion cavity of syngenic fibroblasts genetically modified to secrete hig
19                              When DBA/2 mice syngenic for the tumor were depleted of leukocytes by cy
20  derived from TGFbeta3 null mutant mice into syngenic hosts resulted in a significant inhibition of c
21 dels of breast cancer were utilized: namely, syngenic inbred Lewis female rats bearing the rat mammar
22                                   Orthotopic syngenic intestinal transplantation was performed in Lew
23       Orthotopic left LTxs were performed in syngenic Lewis rats.
24         These T cells lyse parasite-infected syngenic macrophages.
25  syngenic mice injected with three different syngenic mammary tumor cell lines that differ in their m
26 han tamoxifen without any mortality in a rat syngenic mammary tumor model.
27 stration of 1 to Balb/C mice inoculated with syngenic meth/A cells demonstrated statistically signifi
28 nt resource for tracking donor cells in both syngenic MHC-matched and in allogenic MHC-mismatched stu
29 suppress both s.c. implanted TRAMP tumors in syngenic mice as well as orthotopic prostate cancers in
30 e growth of primary tumors and metastasis in syngenic mice by inhibiting the catalytic activity of CD
31 ) interface versus the tumor alone area from syngenic mice injected with three different syngenic mam
32 ore aggressive behavior of tumors growing in syngenic mice, leading to enhanced local invasion into t
33 CCVII tumors that had been preestablished in syngenic mice, resulting in significant prolongation of
34 llantoic membranes of chicken embryos and in syngenic mice.
35 tential upon transplantation into irradiated syngenic mice.
36           Experiments carried out in a mouse syngenic model demonstrated high antitumor activity of 4
37 nd differentiate upon transplantation into a syngenic model of liver repopulation.
38 hat studies in mouse models claimed that the syngenic mouse iPSC lines can be immunogenic.
39  in allogenic myocytes, but had no effect in syngenic myocytes.
40 or fatty rat livers, and an in vivo model of syngenic orthotopic liver transplants in rats.
41                                         In a syngenic orthotopic transplantation model, Prdx4 knockdo
42  Using virgin inbred mice undergoing a first syngenic pregnancy, in which only the male fetuses are a
43                                              Syngenic primary rat fibroblasts genetically modified to
44 nd the effect of preservation solutions in a syngenic rat hindlimb transplant model.
45 t MAA can be adoptively transferred to naive syngenic rats by MAA-primed T cells.
46  kDa) can be adoptively transferred to naive syngenic rats by primed CD4(+) T cells.
47 sease can be adoptively transferred to naive syngenic rats by primed CD4+ T cells.
48 anti-factor B did not transfer EAAU to naive syngenic rats.
49 in response to hormonal induction; otherwise syngenic RB-/- fibroblasts cultured in identical conditi
50 ntestinal organoid units were implanted into syngenic recipient rats.
51 e to euglycemia was significantly shorter in syngenic recipients of BSA/D than DA islets (5.7 +/- 4.8
52 plastic mammary ducts when transplanted into syngenic recipients, whereas cells from Atm(+/+) mice we
53 del was established following inoculation of syngenic SP2/0 cells stably transfected with NS5.
54 d box homeotic gene 3 (PAX3) locus, a region syngenic to mouse chromosome 1.
55                                Allogenic and syngenic transplantation activate the HCMV IE enhancer t
56 kidneys but not significantly different from syngenic transplanted D(5)(-/-) mice, indicating the imp
57 d in C57Bl/6 by intraperitoneal injection of syngenic tumor cells (MC38).
58 e antigen-specific rejection of transplanted syngenic tumor cells.
59  was demonstrated by inoculating mice with a syngenic tumor expressing high levels of human ErbB-2.
60 tic tumor burden in orthotopic xenograft and syngenic tumor models, induced regression of established
61                                              Syngenic TWIST1-positive colon carcinoma cells (CT26) th
62 ) mice and radiation chimeras engrafted with syngenic VIP-KO hematopoietic cells.
63 ons of bone marrow reconstitution, including syngenic, were conducted between the congenic B6 and B6.